SlideGraph+: Whole Slide Image Level Graphs to Predict HER2Status in
Breast Cancer
- URL: http://arxiv.org/abs/2110.06042v1
- Date: Tue, 12 Oct 2021 14:40:15 GMT
- Title: SlideGraph+: Whole Slide Image Level Graphs to Predict HER2Status in
Breast Cancer
- Authors: Wenqi Lu, Michael Toss, Emad Rakha, Nasir Rajpoot, Fayyaz Minhas
- Abstract summary: We propose a novel graph neural network (GNN) based model to predict HER2 status directly from whole-slide images of routine Haematoxylin and Eosin slides.
We demonstrate that the proposed model outperforms the state-of-the-art methods with area under the ROC curve (ordering) values > 0.75 on TCGA and 0.8 on independent test sets.
- Score: 1.8374319565577157
- License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
- Abstract: Human epidermal growth factor receptor 2 (HER2) is an important prognostic
and predictive factor which is overexpressed in 15-20% of breast cancer (BCa).
The determination of its status is a key clinical decision making step for
selection of treatment regimen and prognostication. HER2 status is evaluated
using transcroptomics or immunohistochemistry (IHC) through situ hybridisation
(ISH) which require additional costs and tissue burden in addition to
analytical variabilities in terms of manual observational biases in scoring. In
this study, we propose a novel graph neural network (GNN) based model (termed
SlideGraph+) to predict HER2 status directly from whole-slide images of routine
Haematoxylin and Eosin (H&E) slides. The network was trained and tested on
slides from The Cancer Genome Atlas (TCGA) in addition to two independent test
datasets. We demonstrate that the proposed model outperforms the
state-of-the-art methods with area under the ROC curve (AUC) values > 0.75 on
TCGA and 0.8 on independent test sets. Our experiments show that the proposed
approach can be utilised for case triaging as well as pre-ordering diagnostic
tests in a diagnostic setting. It can also be used for other weakly supervised
prediction problems in computational pathology. The SlideGraph+ code is
available at https://github.com/wenqi006/SlideGraph.
Related papers
- Brain Tumor Classification on MRI in Light of Molecular Markers [61.77272414423481]
Co-deletion of the 1p/19q gene is associated with clinical outcomes in low-grade gliomas.
This study aims to utilize a specially MRI-based convolutional neural network for brain cancer detection.
arXiv Detail & Related papers (2024-09-29T07:04:26Z) - Self-pruning Graph Neural Network for Predicting Inflammatory Disease
Activity in Multiple Sclerosis from Brain MR Images [10.312631192694479]
Multiple Sclerosis (MS) is a severe neurological disease characterized by inflammatory lesions in the central nervous system.
We propose a two-stage MS inflammatory disease activity prediction approach. First, a 3D segmentation network detects lesions, and a self-supervised algorithm extracts their image features.
Second, the detected lesions are used to build a patient graph. The lesions are connected based on their spatial proximity and the inflammatory disease activity prediction is formulated as a graph classification task.
arXiv Detail & Related papers (2023-08-31T17:05:14Z) - Learning to diagnose cirrhosis from radiological and histological labels
with joint self and weakly-supervised pretraining strategies [62.840338941861134]
We propose to leverage transfer learning from large datasets annotated by radiologists, to predict the histological score available on a small annex dataset.
We compare different pretraining methods, namely weakly-supervised and self-supervised ones, to improve the prediction of the cirrhosis.
This method outperforms the baseline classification of the METAVIR score, reaching an AUC of 0.84 and a balanced accuracy of 0.75.
arXiv Detail & Related papers (2023-02-16T17:06:23Z) - Weakly-Supervised Deep Learning Model for Prostate Cancer Diagnosis and
Gleason Grading of Histopathology Images [2.547129771651519]
We propose a weakly-supervised algorithm to classify prostate cancer grades.
The proposed algorithm consists of three steps: extracting discriminative areas in a histopathology image, representing the image, and classifying the image into its Gleason grades.
Results show that the proposed model achieved state-of-the-art performance in the Gleason grading task in terms of accuracy, F1 score, and cohen-kappa.
arXiv Detail & Related papers (2022-12-25T03:07:52Z) - MLC at HECKTOR 2022: The Effect and Importance of Training Data when
Analyzing Cases of Head and Neck Tumors using Machine Learning [0.9166327220922845]
This paper presents the work done by team MLC for the 2022 version of the HECKTOR grand challenge held at MICCAI 2022.
Analysis of Positron Emission Tomography (PET) and Computed Tomography (CT) images has been proposed to identify patients with a prognosis.
arXiv Detail & Related papers (2022-11-30T09:04:27Z) - Interpretable HER2 scoring by evaluating clinical Guidelines through a
weakly supervised, constrained Deep Learning Approach [0.0]
This paper focuses on the interpretability of HER2 scoring by a pathologist.
We propose a semi-automatic, two-stage deep learning approach that directly evaluates the clinical HER2 guidelines.
We achieve a performance of 0.78 in F1-score on the test set while keeping our model interpretable for the pathologist.
arXiv Detail & Related papers (2022-11-17T14:28:35Z) - Lung Cancer Lesion Detection in Histopathology Images Using Graph-Based
Sparse PCA Network [93.22587316229954]
We propose a graph-based sparse principal component analysis (GS-PCA) network, for automated detection of cancerous lesions on histological lung slides stained by hematoxylin and eosin (H&E)
We evaluate the performance of the proposed algorithm on H&E slides obtained from an SVM K-rasG12D lung cancer mouse model using precision/recall rates, F-score, Tanimoto coefficient, and area under the curve (AUC) of the receiver operator characteristic (ROC)
arXiv Detail & Related papers (2021-10-27T19:28:36Z) - Sickle Cell Disease Severity Prediction from Percoll Gradient Images
using Graph Convolutional Networks [38.27767684024691]
Sickle cell disease (SCD) is a severe genetic hemoglobin disorder that results in premature destruction of red blood cells.
Our proposed method is the first computational approach for the difficult task of SCD severity prediction.
arXiv Detail & Related papers (2021-09-11T21:09:50Z) - IA-GCN: Interpretable Attention based Graph Convolutional Network for
Disease prediction [47.999621481852266]
We propose an interpretable graph learning-based model which interprets the clinical relevance of the input features towards the task.
In a clinical scenario, such a model can assist the clinical experts in better decision-making for diagnosis and treatment planning.
Our proposed model shows superior performance with respect to compared methods with an increase in an average accuracy of 3.2% for Tadpole, 1.6% for UKBB Gender, and 2% for the UKBB Age prediction task.
arXiv Detail & Related papers (2021-03-29T13:04:02Z) - An Uncertainty-Driven GCN Refinement Strategy for Organ Segmentation [53.425900196763756]
We propose a segmentation refinement method based on uncertainty analysis and graph convolutional networks.
We employ the uncertainty levels of the convolutional network in a particular input volume to formulate a semi-supervised graph learning problem.
We show that our method outperforms the state-of-the-art CRF refinement method by improving the dice score by 1% for the pancreas and 2% for spleen.
arXiv Detail & Related papers (2020-12-06T18:55:07Z) - Dynamic Graph Correlation Learning for Disease Diagnosis with Incomplete
Labels [66.57101219176275]
Disease diagnosis on chest X-ray images is a challenging multi-label classification task.
We propose a Disease Diagnosis Graph Convolutional Network (DD-GCN) that presents a novel view of investigating the inter-dependency among different diseases.
Our method is the first to build a graph over the feature maps with a dynamic adjacency matrix for correlation learning.
arXiv Detail & Related papers (2020-02-26T17:10:48Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.